HIV is now manageable with consistent medication allowing near-normal life expectancy Pre-exposure prophylaxis (PrEP) drugs prevent HIV infection in high-risk HIV-negative individuals Access to HIV drugs and PrEP is limited by healthcare infrastructure and high drug costs
